Massachusetts Financial Services Co. MA Has $120.61 Million Stake in Chemed Co. (NYSE:CHE)

Massachusetts Financial Services Co. MA cut its stake in Chemed Co. (NYSE:CHE) by 0.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 200,686 shares of the company’s stock after selling 41 shares during the quarter. Massachusetts Financial Services Co. MA owned 1.33% of Chemed worth $120,606,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of the stock. Kayne Anderson Rudnick Investment Management LLC raised its position in Chemed by 2.6% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 580,316 shares of the company’s stock valued at $314,868,000 after buying an additional 14,651 shares during the last quarter. William Blair Investment Management LLC lifted its position in shares of Chemed by 2.7% during the second quarter. William Blair Investment Management LLC now owns 475,372 shares of the company’s stock valued at $257,927,000 after purchasing an additional 12,705 shares in the last quarter. Impax Asset Management Group plc boosted its holdings in Chemed by 4.7% during the third quarter. Impax Asset Management Group plc now owns 332,757 shares of the company’s stock worth $199,977,000 after purchasing an additional 14,814 shares during the last quarter. TD Asset Management Inc grew its stake in Chemed by 10.9% in the 2nd quarter. TD Asset Management Inc now owns 282,753 shares of the company’s stock valued at $153,416,000 after purchasing an additional 27,800 shares during the period. Finally, Epoch Investment Partners Inc. raised its position in Chemed by 22.1% in the second quarter. Epoch Investment Partners Inc. now owns 223,134 shares of the company’s stock worth $121,068,000 after acquiring an additional 40,358 shares during the period. Institutional investors own 95.85% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on CHE. StockNews.com downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Friday. Royal Bank of Canada lowered their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th.

Chemed Price Performance

CHE stock opened at $570.96 on Friday. Chemed Co. has a one year low of $523.33 and a one year high of $654.62. The stock has a market cap of $8.59 billion, a PE ratio of 28.85, a P/E/G ratio of 2.39 and a beta of 0.46. The firm has a 50 day simple moving average of $579.08 and a two-hundred day simple moving average of $565.16.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.32 EPS. On average, research analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed’s dividend payout ratio (DPR) is presently 10.11%.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the transaction, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. This trade represents a 1.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the transaction, the director now directly owns 3,046 shares in the company, valued at approximately $1,819,893.62. The trade was a 11.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 4,113 shares of company stock worth $2,411,905. 3.32% of the stock is currently owned by insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.